About SpinChip
SpinChip is a company based in Oslo (Norway) founded in 2012 was acquired by BioMerieux in January 2025. SpinChip has raised $23.42 million across 3 funding rounds from investors including BioMerieux, Kistefos and Investinor. The company has 30 employees as of December 31, 2021. SpinChip offers products and services including POC Platform and Diagnostic Tests. SpinChip operates in a competitive market with competitors including EKF, LumiraDx, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others.
- Headquarter Oslo, Norway
- Employees 30 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spinchip Diagnostics As
-
Annual Revenue
$671.05 K (USD)-52as on Dec 31, 2022
-
Net Profit
-$2.7 M (USD)-134as on Dec 31, 2022
-
EBITDA
-$3.6 M (USD)-94as on Dec 31, 2022
-
Total Equity Funding
$23.42 M (USD)
in 3 rounds
-
Latest Funding Round
$6.05 M (USD), Series B
Apr 01, 2023
-
Investors
BioMerieux
& 2 more
-
Employee Count
30
as on Dec 31, 2021
-
Acquired by
BioMerieux
(Jan 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpinChip
SpinChip offers a comprehensive portfolio of products and services, including POC Platform and Diagnostic Tests.
Provides all-in-one diagnostic testing for near-patient use in healthcare.
Enables accurate and flexible disease detection with quick results.
People of SpinChip
Unlock access to complete
Funding Insights of SpinChip
SpinChip has successfully raised a total of $23.42M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.05 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SpinChip
SpinChip has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include BioMerieux, Kistefos and Investinor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private investment company managing diversified portfolios is operated.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Developer of diagnostics devices for multiple health purposes
|
Locked | Locked | Locked |
Investor details for SpinChip
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpinChip
Investment portfolio details for SpinChip
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpinChip
Detailed financials for SpinChip
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spinchip Comparisons
Peer comparison for SpinChip
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpinChip
SpinChip operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EKF, LumiraDx, LightDeck Diagnostics, Abaxis and EDX Medical Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
Cloud based diagnostics platform for point of care diagnosing
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for multiplex assays are developed.
|
|
| Locked | Locked | Locked |
Diagnostics company offering a comprehensive line of on-site diagnostic instruments and rapid tests
|
|
| Locked | Locked | Locked |
Medical diagnostics solutions are researched by the laboratory.
|
Detailed competitors of SpinChip
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spinchip
Complete news archive for SpinChip
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpinChip
SpinChip was founded in 2012 and raised its 1st funding round 4 years after it was founded.
SpinChip is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Morten Jurs is the current CEO of SpinChip.
SpinChip is a funded company, having raised a total of $23.42M across 3 funding rounds to date.
As of Dec 31, 2021, the latest employee count at SpinChip is 30.
Annual revenue of SpinChip is $671.05K as on Dec 31, 2022.
SpinChip was founded in 2012 in Oslo, Norway, as an RD-focused entity in the medtech sector. In-vitro diagnostic test cartridges are developed and manufactured by the company, with operations centered on innovative diagnostic solutions. Leadership is provided by CEO Morten Jurs. Activities are conducted primarily in Norway, targeting healthcare applications through cartridge-based testing technologies.
SpinChip offers POC Platform and Diagnostic Tests.
SpinChip has 3 investors. Key investors include BioMerieux, Kistefos, and Investinor.